Login
$TLPH
$0.86 +$0.00 (0.0%) After hours

$TLPH SEC Filings

Filed On Filing
13 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 FORM S-3
12 Nov 2026 FORM 10-Q
12 Nov 2026 8-K: Results of Operations and Financial Condition
12 Aug 2026 SCHEDULE 13G/A
12 Aug 2026 FORM S-8
12 Aug 2026 FORM 10-Q
12 Aug 2026 8-K: Results of Operations and Financial Condition

NEPHRO CRRT clinical study of nafamostat is 75% enrolled; expected to be complete this year

24 Jun 2026 Form 4: Wan Mark A, Director

Received 5,100 shares as a grant or award · Granted 30,700 Stock Option (Right to Buy)

24 Jun 2026 Form 4: Todisco Joseph, Director

Received 5,100 shares as a grant or award · Granted 30,700 Director Stock Option (right to buy)

24 Jun 2026 Form 4: Jain Abhinav, Director

Received 5,100 shares as a grant or award · Granted 30,700 Stock Option (Right to Buy)

24 Jun 2026 Form 4: Hoffman Stephen J, Director

Received 5,100 shares as a grant or award · Granted 30,700 Stock Option (Right to Buy)

24 Jun 2026 Form 4: Broadfoot Jill Marie, Director

Received 5,100 shares as a grant or award · Granted 30,700 Stock Option (Right to Buy)

24 Jun 2026 Form 4: Bozilenko Marina, Director

Received 5,100 shares as a grant or award · Granted 30,700 Stock Option (Right to Buy)

24 Jun 2026 Form 4: Adams Adrian, Director

Received 5,100 shares as a grant or award · Granted 30,700 Stock Option (Right to Buy)

23 Jun 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

(a) Successor to and Continuation of Prior Plan. The Plan is the successor to and continuation of the Prior Plan. As of the Effective Date, (i) no additional awards may be granted under the Prior Plan; (ii) any Returning Shares will beco...

21 May 2026 Form 4: Aslam Shakil, Chief Medical Officer

Gave up 4,518 shares to cover exercise price or tax ($3.72K)

15 May 2026 SCHEDULE 13G/A
13 May 2026 FORM 10-Q
13 May 2026 8-K: Results of Operations and Financial Condition

NEPHRO CRRT clinical study expected to be completed this year

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support